Patents by Inventor Veeresa Gududuru

Veeresa Gududuru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
    Patent number: 7662842
    Abstract: Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
    Type: Grant
    Filed: July 19, 2006
    Date of Patent: February 16, 2010
    Assignees: Ohio State Univesity Research Foundation, The University of Tennessee Research Foundation
    Inventors: Duane D. Miller, James T. Dalton, Veeresa Gududuru, Eunju Hurh
  • THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF
    Publication number: 20090143446
    Abstract: Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
    Type: Application
    Filed: October 22, 2007
    Publication date: June 4, 2009
    Applicants: OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Duane D. Miller, Veeresa Gududuru, James T. Dalton, Eunju Hurh
  • Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
    Patent number: 7307093
    Abstract: Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: December 11, 2007
    Assignees: The University of Tennessee Research Foundation, Ohio State University Research Foundation
    Inventors: Duane D. Miller, Veeresa Gududuru, James T. Dalton, Eunju Hurh
  • THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS
    Publication number: 20070155807
    Abstract: Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
    Type: Application
    Filed: July 19, 2006
    Publication date: July 5, 2007
    Applicants: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Duane Miller, James Dalton, Veeresa Gududuru, Eunju Hurh
  • LPA2 receptor agonist inhibitors of CFTR
    Publication number: 20070078111
    Abstract: Methods and compositions for treating or preventing diarrhea are disclosed. The methods comprise administering to an individual a therapeutically effective amount of an LPA2 receptor agonist for treating or preventing diarrhea. Also disclosed is a method of inhibiting CFTR activation by administering at least one LPA2 receptor agonist in an amount effective to inhibit formation of a macromolecular complex between the LPA2 receptor, CFTR, and a Na+/H+ exchange regulatory factor-2 (NHERF-2).
    Type: Application
    Filed: July 19, 2006
    Publication date: April 5, 2007
    Inventors: Gabor Tigyi, Duane Miller, Leonard Johnson, Veeresa Gududuru, Anjaparavanda Naren, Chunying Li, Wenlin Deng, Gangadhar Durgam
  • Acetal phosphate-derived LPA mimics, PPARgamma activators, and autotaxin inhibitors
    Publication number: 20060270634
    Abstract: Disclosed are compositions that modulate the effects of extracellular LPA receptors, the intracellular PPAR? receptor, and autotaxin, and methods for their use.
    Type: Application
    Filed: May 6, 2006
    Publication date: November 30, 2006
    Inventors: Duane Miller, Gabor Tigyi, Veeresa Gududuru, Yuko Fujiwara, Daniel Baker, Michelle Walker, Gangadar Durgam
  • Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
    Publication number: 20060040998
    Abstract: Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
    Type: Application
    Filed: November 18, 2004
    Publication date: February 23, 2006
    Inventors: Duane Miller, Veeresa Gududuru, James Dalton, Eunju Hurh
  • Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
    Publication number: 20060014740
    Abstract: Analogs exhibiting inhibition of cell proliferation are provided. Methods of making the analogs are also included. The analogs can be used to treat cancerous conditions such as prostate, breast, and ovarian cancer.
    Type: Application
    Filed: February 11, 2005
    Publication date: January 19, 2006
    Inventors: Duane Miller, James Dalton, Veeresa Gududuru, Eunju Hurh